Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039615 | SCV000063304 | likely benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | p.Ile2332Phe in exon 32 of GPR98: This variant is not expected to have clinical significance because it has been identified in 0.3% (28/10072) of Ashkenazi Jewi sh chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadin stitute.org; dbSNP rs193030567). |
Gene |
RCV000725221 | SCV000168707 | likely benign | not provided | 2020-05-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26969326) |
Eurofins Ntd Llc |
RCV000725221 | SCV000335100 | uncertain significance | not provided | 2015-09-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000725221 | SCV000883364 | uncertain significance | not provided | 2017-12-29 | criteria provided, single submitter | clinical testing | The ADGRV1 p.Ile2332Phe variant (rs193030567) was reported in one individual with a diagnosis of Usher syndrome type 2C who also harbored the p.Val617Met variant (Sloan-Heggen 2016). The p.Ile2332Phe variant is listed in the Genome Aggregation Database (gnomAD) with an allele frequency of 0.3 percent in the Ashkenazi Jewish population (identified on 28 out of 10,072 chromosomes) and has been reported to the ClinVar database (Variation ID: 46359). The isoleucine at position 2332 is highly conserved considering 12 species up to zebrafish (Alamut software v2.10.0), and computational analyses predict that this variant does affect the structure/function of the ADGRV1 protein (SIFT: damaging, MutationTaster: disease causing, PolyPhen-2: possibly damaging). Altogether, there is not enough evidence to classify the p.Ile2332Phe variant with certainty. |
Mendelics | RCV000987537 | SCV001136853 | benign | Usher syndrome type 2C | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000987537 | SCV001312707 | uncertain significance | Usher syndrome type 2C | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Labcorp Genetics |
RCV000725221 | SCV001730669 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
DECIPHERD- |
RCV000987537 | SCV004101829 | uncertain significance | Usher syndrome type 2C | 2023-07-01 | criteria provided, single submitter | research | |
Ce |
RCV000725221 | SCV004159116 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737181 | SCV005365358 | likely benign | ADGRV1-related disorder | 2024-08-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |